Related references
Note: Only part of the references are listed.Caveolae-mediated Tie2 signaling contributes to CCM pathogenesis in a brain endothelial cell-specific Pdcd10-deficient mouse model
Huanjiao Jenny Zhou et al.
NATURE COMMUNICATIONS (2021)
Propranolol inhibits cavernous vascular malformations by β1 adrenergic receptor antagonism in animal models
Wenqing Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Propranolol Reduces the Development of Lesions and Rescues Barrier Function in Cerebral Cavernous Malformations A Preclinical Study
Joppe Oldenburg et al.
STROKE (2021)
PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism
Aileen A. Ren et al.
NATURE (2021)
Neurological outcomes of untreated brainstem cavernous malformations in a prospective observational cohort and literature review
Da Li et al.
STROKE AND VASCULAR NEUROLOGY (2021)
The multifaceted PDCD10/CCM3 gene
Mariaelena Valentino et al.
GENES & DISEASES (2021)
Astrocytes propel neurovascular dysfunction during cerebral cavernous malformation lesion formation
Miguel Alejandro Lopez-Ramirez et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Novel Chronic Mouse Model of Cerebral Cavernous Malformations
Cecile Cardoso et al.
STROKE (2020)
High Prevalence of Spinal Cord Cavernous Malformations in the Familial Cerebral Cavernous Malformations Type 1 Cohort
M. C. Mabray et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2020)
Propranolol for familial cerebral cavernous malformation (Treat_CCM): study protocol for a randomized controlled pilot trial
Silvia Lanfranconi et al.
TRIALS (2020)
Novel Murine Models of Cerebral Cavernous Malformations
Matthew R. Detter et al.
ANGIOGENESIS (2020)
Mapping endothelial-cell diversity in cerebral cavernous malformations at single-cell resolution
Fabrizio Orsenigo et al.
ELIFE (2020)
Cell circuits and niches controlling B cell development
Sandra Zehentmeier et al.
IMMUNOLOGICAL REVIEWS (2019)
Endothelial cell clonal expansion in the development of cerebral cavernous malformations
Matteo Malinyerno et al.
NATURE COMMUNICATIONS (2019)
Distinct cellular roles for PDCD10 define a gut-brain axis in cerebral cavernous malformation
Alan T. Tang et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Cerebral cavernous malformations form an anticoagulant vascular domain in humans and mice
Miguel Alejandro Lopez-Ramirez et al.
BLOOD (2019)
Plasma Biomarkers of Inflammation Reflect Seizures and Hemorrhagic Activity of Cerebral Cavernous Malformations
Romuald Girard et al.
TRANSLATIONAL STROKE RESEARCH (2018)
Plasma Biomarkers of Inflammation and Angiogenesis Predict Cerebral Cavernous Malformation Symptomatic Hemorrhage or Lesional Growth
Romuald Girard et al.
CIRCULATION RESEARCH (2018)
Cerebral Cavernous Malformations Develop Through Clonal Expansion of Mutant Endothelial Cells
Matthew R. Detter et al.
CIRCULATION RESEARCH (2018)
Review of familial cerebral cavernous malformations and report of seven additional families
Ivo J. H. M. de Vos et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2017)
Thrombospondin1 (TSP1) replacement prevents cerebral cavernous malformations
Miguel Alejandro Lopez-Ramirez et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Endothelial TLR4 and the microbiome drive cerebral cavernous malformations
Alan T. Tang et al.
NATURE (2017)
Endothelial cell disease: emerging knowledge from cerebral cavernous malformations
Maria Grazia Lampugnani et al.
CURRENT OPINION IN HEMATOLOGY (2017)
KLF4 is a key determinant in the development and progression of cerebral cavernous malformations
Roberto Cuttano et al.
EMBO MOLECULAR MEDICINE (2016)
B-Cell Depletion Reduces the Maturation of Cerebral Cavernous Malformations in Murine Models
Changbin Shi et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2016)
Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling
Zinan Zhou et al.
NATURE (2016)
Endothelial exocytosis of angiopoietin-2 resulting from CCM3 deficiency contributes to cerebral cavernous malformation
Huanjiao Jenny Zhou et al.
NATURE MEDICINE (2016)
A Randomized, Controlled Trial of Oral Propranolol in Infantile Hemangioma
C. Leaute-Labreze et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Sulindac metabolites decrease cerebrovascular malformations in CCM3-knockout mice
Luca Bravi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Polymorphisms in Inflammatory and Immune Response Genes Associated with Cerebral Cavernous Malformation Type 1 Severity
Helene Choquet et al.
CEREBROVASCULAR DISEASES (2014)
Surgical outcomes and natural history of intramedullary spinal cord cavernous malformations: a single-center series and meta-analysis of individual patient data
Jetan H. Badhiwala et al.
JOURNAL OF NEUROSURGERY-SPINE (2014)
EndMT contributes to the onset and progression of cerebral cavernous malformations
Luigi Maddaluno et al.
NATURE (2013)
Natural history and imaging prevalence of cavernous malformations in children and young adults Clinical article
Wajd N. Al-Holou et al.
JOURNAL OF NEUROSURGERY-PEDIATRICS (2012)
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin et al.
NATURE METHODS (2012)
Developmental timing of CCM2 loss influences cerebral cavernous malformations in mice
Gwenola Boulday et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Management of incidental cavernous malformations: a review
Richard T. Dalyai et al.
NEUROSURGICAL FOCUS (2011)
Cerebral Cavernous Malformation 2 Protein Promotes Smad Ubiquitin Regulatory Factor 1-mediated RhoA Degradation in Endothelial Cells
Lisa E. S. Crose et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases
Kevin J. Whitehead et al.
NATURE MEDICINE (2009)
Immune Response in Human Cerebral Cavernous Malformations
Changbin Shi et al.
STROKE (2009)
Vertebral and spinal cavernous angiomas associated with familial cerebral cavernous malformation
Irene Toldo et al.
SURGICAL NEUROLOGY (2009)
Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis
Zoe Morris et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Cerebral cavernomas and human leukocyte antigens: preliminary clinical results
Galip Zihni Sanus et al.
SURGICAL NEUROLOGY (2007)
Coexistence of intracranial and spinal cavernous malformations: a study of prevalence and natural history
AA Cohen-Gadol et al.
JOURNAL OF NEUROSURGERY (2006)
Prospective follow-up of 33 asymptomatic patients with familial cerebral cavernous malformations
P Labauge et al.
NEUROLOGY (2001)
De novo lesions in familial form of cerebral cavernous malformations: Clinical and MR features in 29 non-hispanic families
L Brunereau et al.
SURGICAL NEUROLOGY (2000)